Inhibitory effect of polyozellin on secretory group IIA phospholipase A2.

about

Inhibitory effect of polyozellin on secretory group IIA phospholipase A2.

Item

http://www.wikidata.org/entity/Q40873955

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Inhibitory effect of polyozellin on secretory group IIA phospholipase A2.

@en

type

Item

label

Inhibitory effect of polyozellin on secretory group IIA phospholipase A2.

@en

prefLabel

Inhibitory effect of polyozellin on secretory group IIA phospholipase A2.

@en

P1476

Inhibitory effect of polyozellin on secretory group IIA phospholipase A2.

@en

P2093

Byeongjin Jung

http://www.w3.org/2001/XMLSchema#string

Eun-Ju Yang

http://www.w3.org/2001/XMLSchema#string

Hyejin Kang

http://www.w3.org/2001/XMLSchema#string

Jong-Sup Bae

http://www.w3.org/2001/XMLSchema#string

Sae-Kwang Ku

http://www.w3.org/2001/XMLSchema#string

P2860

The functions of five distinct mammalian phospholipase A2S in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2S are functionally redundant and act in concert with cytosolic phospholipase A2

The expanding superfamily of phospholipase A(2) enzymes: classification and characterization

Regulation and inhibition of phospholipase A2.

A prolyl endopeptidase-inhibiting benzofuran dimer from Polyozellus multiflex.

Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro

Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo

Inhibitory effects of oroxylin A on endothelial protein C receptor shedding in vitro and in vivo.

Polyozellus multiplex, a Korean wild mushroom, as a potent chemopreventive agent against stomach cancer.

Potential anti-angiogenesis effects of p-terphenyl compounds from Polyozellus multiplex.

Polyozellin inhibits nitric oxide production by down-regulating LPS-induced activity of NF-kappaB and SAPK/JNK in RAW 264.7 cells.

P2888

s12272-015-0694-4

P304

271-278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12272-015-0694-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1017438688

http://www.w3.org/2001/XMLSchema#string

P698

26659873

http://www.w3.org/2001/XMLSchema#string